Our medicines
Rezzayo®
(rezafungin acetate) powder for concentrate for solution for infusion
Prescribing information for
Pelmeg®
(pegfilgrastim) solution for injection in pre-filled syringe
Prescribing information for
Adizem-XL®
(diltiazem hydrochloride) prolonged release capsules
For prescribing information
Adizem-SR®
(diltiazem hydrochloride) prolonged release capsules
For prescribing information
Pelmeg®
(pegfilgrastim) solution for injection in pre-filled syringe
Prescribing information for
Important Safety Information
- Long-term use of opioid medicines carries an increased risk of dependence and addiction
- Discuss with patients that prolonged use of opioids may lead to drug dependence and addiction, even at therapeutic doses
- Before starting treatment with opioids, agree with the patient a treatment strategy and plan for end of treatment
- Opioid medicines and benzodiazepines (or benzodiazepine-like drugs) can both cause respiratory depression. When used together, additive effects on the central nervous system increase the risks of sedation, respiratory depression, coma, and death. Only prescribe opioids and benzodiazepines (or benzodiazepine-like drugs) together if there is no alternative
- For further information, please refer to product prescription information and advice for healthcare professionals https://www.gov.uk/drug-safety-update/opioids-risk-of-dependence-and-addiction AND https://www.gov.uk/drug-safety-update/benzodiazepines-and-opioids-reminder-of-risk-of-potentially-fatal-respiratory-depression
OxyContin®
(oxycodone hydrochloride) prolonged release tablets
For prescribing information
OxyNorm®
(oxycodone hydrochloride)10 mg/ml solution for injection or infusion
For prescribing information
OxyNorm®
(oxycodone hydrochloride)50 mg/ml solution for injection or infusion
For prescribing information
Palladone® SR
(hydromorphone hydrochloride) prolonged release capsules
For prescribing information
Palladone®
(hydromorphone hydrochloride) solution for injection or infusion
For prescribing information
Targinact®
(oxycodone hydrochloride/ naloxone hydrochloride) prolonged release tablets
For prescribing information
Overdose Therapy
Addiction is a complex, relapsing, chronic disease, which can carry serious health and social consequences. At Napp, we share the concerns of patients and their families working through the illness of heroin addiction, and believe that people living with heroin addiction deserve the best available care. Overdose is a dangerous potential consequence of opioid misuse or abuse, and in particular abuse of illegal heroin. By supplying Nyxoid, Napp are providing another option for treating such instances of overdose.
Nyxoid®
(naloxone hydrochloride dihydrate) intranasal spray
Prescribing information for
flutiform®
(fluticasone propionate / formoterol fumarate dihydrate) pressurised metered dose inhaler
For prescribing information